Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2025-12-24 @ 5:21 PM
NCT ID:
NCT03523650
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosis of isolated or familial cavernous malformation syndrome:
* symptomatic cavernous malformation not amenable to surgical resection.
* familial cavernous malformation with seizure, other neurological symptom or surgically inaccessible lesion.
2. Written and informed consent obtained prior to study enrollment.
3. Subject is able and willing to return for outpatient visits.
4. Negative pregnancy test at time of enrollment for women and child-bearing potential.
Exclusion Criteria:
1. Age less than 1 year-old.
2. Propranolol allergy or allergy to other b-blockers.
3. Estimated life expectancy of less than 1 year.
4. History of severe anemia, cardiac dysfunction, or diabetes.
5. A psychiatric or substance abuse problem that may interfere with study compliance.
6. Pregnant and lactating women.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
80 Years
Study:
NCT03523650
Study Brief:
Protocol Section:
NCT03523650